The insulin resistance syndrome revisited

Diabetes Care

Volumn 19, Issue 3, 1996, Pages 275-277

  Haffner, Steven M ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; LIPOPROTEIN; PROINSULIN;

ATHEROGENESIS; ATHEROSCLEROSIS; CONFERENCE PAPER; CORONARY RISK; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; LIPOPROTEIN METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK FACTOR;

EID: 0030049426     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.19.3.275     Document Type: Conference Paper

References (43)

1. Modan M, Halkin H, Almog S, Lusky A, Eshkol A, Shefi M, Shitrit A, Fuchs Z: Hyperinsulinemia: a link between hypertension, obesity and glucose intolerance J Clin Invest 75:809-817, 1985
2. Zavaroni I, Bonora E, Pagliara M, Dall'Aglio E, Luchetti L, Buonanno G, Bonati PA, Bergonzani M, Gnudi L, Passeri M, Reaven G. Risk factors for coronary artery disease in healthy persons with hyperin-sulinemia and normal glucose tolerance. N Engl J Med 320:702-706, 1989
3. Orchard TJ, Becker DJ, Bates M, Kuller LH, Drash AL: Plasma insulin and lipoprotein concentrations: an atherogenic association? Am J Epidemiol 118:326-337, 1983
4. Haffner SM, Fong D, Hazuda HP, Pugh JA, Patterson JK: Hyperinsulinemia, upper body adiposity, and cardiovascular risk factors in non-diabetics. Metabolism 37: 338-345, 1988
5. DeFronzo RA, Ferrannini E: Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diabetes Care 14:173-194, 1991
6. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, Pedrinelli R, Brandi L, Bevilacqua S: Insulin resistance in essential hypertension. N Engl J Med 317:350-357, 1987
7. Garg A, Helderman JH, Koffler M, Ayuso R, Rosenstock J, Raskin P: Relationship between lipoprotein levels and in vivo insulin action in normal young white men. Metabolism 37:982-987, 1988
8. Abbott WGH, Lillioja S, Young AA, Zawadzki JK, Yki-Jarvinen H, Christin L, Howard BV: Relationships between plasma lipoprotein concentrations and insulin action in an obese hyperinsulinemic population. Diabetes 36:897-904, 1987
9. Reaven GM: Banting Lecture 1988: Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988
10. Jarrett RJ. Is insulin atherogenic? Diabetologia 31:71-75, 1988
11. Mbanya JCN, Thomas TH, Wilkinson R, Alberti KGMM, Taylor R: Hypertension and hyperinsulinemia: a relation in diabetes but not in essential hypertension. Lancet i:733-734, 1988
12. Haffner SM: Editorial: Insulin and blood pressure: fact or Fantasy? J Clin Endocrinol Metab 76 541-543, 1993
13. Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP: Prospective analysis of the insulin resistance syndrome (syndrome X). Diabetes 41: 715-722, 1992
14. Mykkänen L, Kuusisto J, Pyöralä K, Laakso M Cardiovascular disease risk factors as predictors of type II (non-insulin-dependent) diabetes mellitus in elderly subjects. Diabetologia 36:553-559, 1993
15. Duncan B, Schmidt MI, Sharrett AR, Watson R, Brancati F, Heiss G: Association of fasting insulin with clustering of metabolic abnormalities in African Americans and whiles (Abstract). Diabetes, 43 (Suppl. 1):150, 1994
16. Mykkanen L, Rönnemaa T, Laakso M: Low insulin sensitivity is associated with a clustering of cardiovascular risk factors (Abstract). Diabetes 43 (Suppl. 1):150, 1994
17. Mykkänen L, Kuusisto J, Haffner SM, Pyöräla K, Laakso M: Hyperinsulinemia predicts multiple atherogenic changes in lipoproteins in elderly subjects. Arterioscler Thromb 14:518-526, 1994
18. Karhapäa P, Voutilainen E, Kovanen PT, Laakso M. Insulin resistance in familial and non-familial hypercholesterolemia. Arterioscler Thromb 13:41-48, 1993
19. Selby JV, Austin MA, Newman B, Zhang D, Quesenberry CP Jr, Mayer EJ, Krauss RM: LDL subclass phenotypes and the insulin resistance syndrome in women. Circulation 88:381-387, 1993
20. Haffner SM, Mykkänen L, Valdez RA, Paidi M, Stern MP, Howard BV: Low densay lipoprotein size and subclass pattern in a biethnic population. Arterioscler Thromb 13:1623-1630, 1993
21. Reaven GM, Chen YDI, Jeppesen J, Mahetix P, Krauss RM: Insulin resistance and hyperinsulinemia in individuals with small dense, low density lipoprotein particles. J Clin Invest 92:141-146, 1993
22. Porte D: Banting Lecture 1990: β cells in type II diabetes mellitus. Diabetes 40: 166-180, 1991
23. Philips DI, Clark PM, Hales CN, Osmond C: Understanding oral glucose tolerance: comparison of glucose and insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion. Diabetic Med 11:286-292, 1994
24. Mykkänen L, Hales CN, Ronnemaa T, Laakso M: The relation of proinsulin, insulin and proinsulin-to-insulin ratio with insulin sensitivity (Abstract). Diabetes 44 (Suppl. 1):125, 1995.
25. Temple RC, Carrington CA, Luzio SD, Owens DR, Schneider AE, Sobey WJ, Hales CN: Insulin deficiency in non-insulin-dependent diabetes. Lancet i:293-295, 1989
26. Ward WK, LaCava EC, Paquette TL, Beard JC, Wallum BJ, Porte D: Disproportionate elevation of immunoreactive proinsulin in type II (non-insulin-dependent) diabetes mellitus and in experimental insulin resistance. Diabetologia 30:698-702, 1987
27. Saad MF, Kahn SE, Nelson RG, Pettitt DJ, Knowler WC, Schwartz MW, Kowalyk S, Bennett PH, Porte D: Disproportionately elevated proinsulin in Pima Indians with non-insulin dependent diabetes mellitus J Clin Endocrinol Metab 70:1247-1257, 1990
28. Haffner SM, Bowsher RR, Mykkänen L, Hazuda HP, Mitchell BD, Valdez RA, Gingerich R, Monterrosa A, Stern MP: Proinsulin and specific insulin concentrations in high and low risk populations for non-insulin dependent diabetes mellitus. Diabetes 43:1490-1493, 1994
29. Davies M, Rayman G, Gray IP, Day GL, Hales CN: Insulin deficiency and increased plasma concentrations of intact and 32/33 split proinsulin in subjects with impaired glucose tolerance. Diabetic Med 10:313-320, 1993
30. Nagi DK, Hendra TJ, Ryle AJ, Cooper TM, Temple RC, Clark PMS, Schneider AE, Hales CN, Yudkin JS: The relationships of concentrations of insulin, intact proinsulin and 32-33 split proinsulin with cardiovascular risk factors in type II (non-insulin dependent) diabetic subjects. Diabetologia 33:532-537, 1990
31. Haffner SM, Mykkänen L, Stern MP, Valdez RA, Heisserman JA, Bowsher RR: Relationship of proinsulin and insulin to cardiovascular risk factors in non-diabetic subjects. Diabetes 42:1297-1302, 1993
32. Haffner SM, Mykkänen L, Valdez RA, Stern MP, Holloway DL, Monterrosa A, Bowsher RR. Disproportionately increased proinsulin levels are associated with the insulin resistance syndrome. J Clin Endocrinol Metab 79:1806-1810, 1994
33. Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Mott DM, Bennett PH: Sequential changes in serum insulin concentrations during development of non-insulin dependent diabetes. Lancet i: 1356-1359, 1989
34. Sicree RA, Zimmet PZ, King HOM, Coventry JS: Plasma insulin response among Nauruans. Prediction of deterioration in glucose tolerance over 6 years. Diabetes 36 179-186, 1987
35. Haffner SM, Stern MP, Mitchell BD, Hazuda HP, Patterson JK: Incidence of type II diabetes in Mexican Americans predicted by fasting insulin and glucose levels, obesity and body fat distribution. Diabetes 39 283-288, 1990
36. Hamman RF: Genetic and environmental determinants of non-insulin dependent diabetes mellitus (NlDDM) Diabetes Metab Rev 8:287-378, 1992
37. Bergstrom RW, Newell-Morris LL, Leonetti DL, Shuman WT, Wahl PW, Fujimoto WY: Association of elevated C-peptide level and increased intra-abdominal fat distribution with development of NlDDM in Japanese-American men. Diabetes 39:104-111, 1990
38. Charles MA, Fontbonne A, Thibult N, Warnet JM, Rosselin GE, Eschwege E: Risk factors for NIDDM in white population: Pans Prospective Study Diabetes 40: 796-799, 1991
39. Warram JH, Martin BC, Krolewski AS, Soeldner JS, Kahn CR: Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents Ann Intern Med 113:909-915, 1990
40. Lillioja S, Mott DM, Spraul M, Ferraro R, Foley JE, Ravussin E, Knowler WC, Bennett PH, Bogardus C: Insulin resistance and insulin secretory dysfunction as precursors of non-insulin dependent diabetes mellitus: prospective studies of Pima Indians. N Engl J Med 329 1988-1992, 1993
41. Haffner SM, Miettinen H, Gaskill SP, Stem MP: Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans. Diabetes 44:1386-1391, 1995
42. Mykkänen L, Kuusisto J, Hales CN, Pyorälä K, Laakso M, Haffner SM: Serum proinsulin levels are disproportionately increased in elderly prediabetic subjects (Abstract). Diabetologia 37 (Suppl 1): A74, 1994..
43. Kahn SE, Leonetti DL, Prigeon RL, Boyko EJ, Bergstrom RW, Fujimoto WY: Proinsulin as a marker for the development of NlDDM in Japanese American men (Abstract). Diabetes 43 (Suppl. 1):151A, 1994